FDA | The Business Standard
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard
THURSDAY, MAY 26, 2022
THURSDAY, MAY 26, 2022
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা

FDA

 Eli Lilly logo is shown on one of the company's offices in San Diego, California, US, September 17, 2020. Photo: Reuters
USA

US FDA authorizes Eli Lilly's Covid-19 antibody drug

The company on Thursday signed a supply deal with the US government for up to 600,000 doses of bebtelovimab to be delivered by the end of March

A vial labelled with the Pfizer-BioNTech coronavirus disease (Covid-19) vaccine is seen in this illustration picture taken March 19, 2021. Photo :Reuters
Coronavirus chronicle

Pfizer asks FDA to allow Covid-19 vaccine for kids under 5

An ampule of Remdesivir is pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg, Germany, April 8, 2020, as the spread of coronavirus disease (Covid-19) continues. Photo :Reuters
USA

FDA expands use of remdesivir to patients with high risk of hospitalization

A health worker prepares a booster dose of a coronavirus disease (Covid-19) vaccine, as vaccinations jump in Italy after the government made inoculation mandatory for all workers, in Rome, Italy. Photo: Reuters
Coronavirus chronicle

US FDA may approve Covid-19 booster without outside advisory panel opinion -CNN

Vials of the Pfizer-BioNTech Covid-19 vaccine sit in a cooler before being thawed at a pop-up Covid-19 vaccination site in the Bronx borough of New York on Tuesday, Jan. 26, 2021. On Tuesday, Nov. 9, 2021, Pfizer asked US regulators to allow boosters of its Covid-19 vaccine for anyone 18 or older, a step that comes amid concern about increased spread of the coronavirus with holiday travel and gatherings. Photo: UNB/AP
Coronavirus chronicle

Pfizer asks FDA to OK Covid-19 booster shots for all adults

REUTERS/Dado Ruvic/Illustration
Coronavirus chronicle

Moderna says FDA needs more time to complete review of its Covid-19 shot for adolescents

Photo :Reuters
Coronavirus chronicle

US FDA authorizes first Covid-19 shot for young kids

A vial labelled with the Pfizer-BioNTech coronavirus disease (Covid-19) vaccine is seen in this illustration picture taken March 19, 2021. Photo :Reuters
Coronavirus chronicle

US FDA advisers back Pfizer/BioNTech Covid-19 vaccine for children

A woman holds a small bottle labelled with a "Coronavirus Covid-19 Vaccine" sticker and a medical syringe in this illustration taken October 30, 2020. REUTERS/Dado Ruvic/File Photo
Coronavirus chronicle

FDA says benefits outweigh risks for Pfizer/BioNTech Covid-19 vaccine in children

A medical worker displays a vial with a coronavirus disease (Covid-19) vaccine at a vaccination centre in Tehran, Iran Sept 20, 2021. Majid Asgaripour/REUTERS
Coronavirus chronicle

Second J&J Covid shot gets expert backing; FDA looking at lowering age for Pfizer booster

Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo
USA

US FDA gives marketing nod to an e-cigarette for the first time

The Merck logo is seen at a gate to the Merck & Co campus in Rahway, New Jersey, US, July 12, 2018. REUTERS/Brendan McDermid
Coronavirus chronicle

Merck seeks first US FDA authorisation for Covid-19 tablet

A parent walks their children on the first day of school, amid the coronavirus (Covid-19) pandemic, at West Tampa Elementary School in Tampa, Florida, US, August 10, 2021. Photo :Reuters
Coronavirus chronicle

US could authorize Pfizer Covid-19 shot for kids age 5-11 in October -sources

  • Show More
The Business Standard
Top
  • Home
  • Entertainment
  • Sports
  • About Us
  • Bangladesh
  • International
  • Privacy Policy
  • Comment Policy
  • Contact Us
  • Economy
  • Sitemap
  • RSS

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net

Copyright © 2022 THE BUSINESS STANDARD All rights reserved. Technical Partner: RSI Lab